Semaglutide, more commonly known as Ozempic, can do more than help with weight loss. A new clinical trial shows it helps ...

Patients will lose access to cheaper versions of the blockbuster drugs after the agency shuts down the multibillion-dollar industry now that the drug shortage has ended. Also in the news: Eli Lilly's ...

Semaglutide may relieve peripheral arterial disease experienced by many patients with type 2 diabetes, a new Montreal study ...

The drug semaglutide, found in popular brands like Wegovy and Ozempic, looks especially promising ... had type 2 diabetes and had no signs of Alzheimer's disease or other types of dementia ...

Semaglutide is one type of GLP-1RA drug approved in the UK for diabetes management (Ozempic) and weight loss ... lower risk of developing Alzheimer’s disease, while SGLT2i users had a 43 ...

Semaglutide — the powerful ingredient behind Wegovy and Ozempic — has long been hailed ... promising in reducing the risk of Alzheimer's disease and related dementias (ADRD)'.

Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.

1:39 Dr. Daniel Drucker talks about the ‘celebrity culture’ use of Ozempic “We have students ... and we’ve done experiments on heart disease and inflammation and kidney disease and liver ...

Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes. (HealthDay News) — For patients with symptomatic peripheral ...

You've probably heard of GLP-1s, a class of drugs that includes semaglutide (Ozempic). The drugs were developed to manage type 2 diabetes and are now widely being used to help with weight loss.